Geneviève Garon

机构：Toronto General Hospital, Sanofi (Canada), University of Colorado Denver · ORCID：0009-0001-0486-6325

发表论文 24 篇 · 总被引 323 次 · h-index 9

代表论文

• Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests (2023 · Circulation · 被引 60)
• Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial (2023 · Journal of the American Heart Association · 被引 41)
• Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia (2024 · Archives of Pediatrics and Adolescent Medicine · 被引 36)
• Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes (2010 · Journal of Clinical Pathology · 被引 35)
• Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study (2024 · Journal of clinical lipidology · 被引 26)
• Analytical Performance of a qRT-PCR Assay to Detect Guanylyl Cyclase C in FFPE Lymph Nodes of Patients With Colon Cancer (2010 · Diagnostic Molecular Pathology · 被引 26)